Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interleukin-12 for Plateau Phase Multiple Myeloma
NCT00003149Phase 2Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Dec 1997
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant interleukin-12 in multiple myeloma (MM), sponsored by Eastern Cooperative Oncology Group. Started Dec 1997; status: completed.
02
Drugs
recombinant interleukin-12
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00003149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003149.